U.S. company Medgene granted USDA license to provide solutions for pork producers

One of the largest veterinary companies in the USA, Medgene, has obtained a license to produce vaccines adressing most dangerous diseases of pigs.

The Center for Veterinary Biology of the US Department of Agriculture has issued a license to the animal health company Medgene for the production and marketing of the Platform vaccine approved by the US Department of Agriculture for the pig industry. Medgene announced their licensure at the World Pork Expo, located in Des Moines, Iowa.

The license applies to use of their Platform technology to produce vaccines addressing disease targets such as rotavirus, porcine circovirus, influenza A and sapovirus. It is not specified whether ASF is included in this list. The result is the development of vaccines and an understanding of how diseases move across species and geographies in a fraction of the time of traditional vaccine approaches. Medgene's approach to Platform Vaccines allows us to keep mational standards of animal health at the highest level possible.

The pig industry is critically important for U.S. food security.

SOURCE: meatinfo